Sol-Gel Technologies Ltd. (SLGL)
69.50
+1.19
(+1.74%)
USD |
NASDAQ |
Jan 16, 16:00
68.99
-0.51
(-0.73%)
After-Hours: 20:00
Sol-Gel Technologies EPS Diluted (Quarterly): -2.133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.942M |
| Revenue (Quarterly) | 0.40M |
| Total Expenses (Quarterly) | 6.342M |
| Enterprise Value | 173.85M |
| Profit Margin (Quarterly) | -1.49K% |
| Earnings Yield | -4.64% |
| Normalized Earnings Yield | -4.641 |